HT
ACAD icon

HAP Trading’s Acadia Pharmaceuticals ACAD Stock Holding History

HAP Trading’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,097
Closed -$251K – 2488
2021
Q3 		$251K Buy
+15,097
New +$291K 0.01% 948
2018
Q3 		– Sell
-82,437
Closed -$1.3M – 978
2018
Q2 		$1.26M Buy
+82,437
New +$1.47M 0.06% 213
2016
Q2 		– Sell
-49,430
Closed -$1.65M – 889
2016
Q1 		$1.38M Buy
+49,430
New +$1.08M 0.1% 169
2014
Q1 		– Sell
-24,155
Closed -$604K – 976
2013
Q4 		$604K Sell
24,155
-8,610
-26% -$203K 0.02% 545
2013
Q3 		$900K Buy
+32,765
New +$685K 0.03% 388

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

HAP Trading's ACAD Position: Q4 2021 in Review

HAP Trading sold out of Acadia Pharmaceuticals (ACAD) in Q4 2021, closing a stake of 15,097 shares — an estimated $251K sold.

HAP Trading first reported a position in ACAD in Q3 2013 and held it in 5 quarters. The position peaked at $1.38M in Q1 2016. 247 funds tracked by Wall St. Rank hold ACAD as of Q4 2021.

  • HAP Trading reported no remaining Acadia Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 15,097 Acadia Pharmaceuticals shares in Q4 2021, an estimated $251K.
  • HAP Trading first reported a position in Acadia Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • HAP Trading's Acadia Pharmaceuticals position peaked at $1.38M in Q1 2016.
  • 247 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.